Baxter International
American manufacturer of healthcare goods
BAX NYSE
ISIN US0718131099 SEC CIK 10456
Follow Baxter International
Weekly email: filings, results
Revenue, last quarter
$3B
+5% vs same quarter last year
Net income
$294M
+739.1% vs same quarter last year
EPS, diluted
$0.57
+733.3% vs same quarter last year
Operating cash flow
$558M
+135.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $11.2B | −$957M |
| FY24 | $10.6B | −$649M |
| FY23 | $10.4B | $2.7B |
| FY22 | $10.1B | −$2.4B |
| FY21 | $12.1B | $1.3B |
| FY20 | $11.7B | $1.1B |
| FY19 | $11.4B | $1B |
| FY18 | $11.1B | $1.5B |
| FY17 | $10.6B | $602M |
| FY16 | $10.2B | $5B |
| FY15 | $10B | $968M |
| FY14 | $10.7B | $2.5B |
| FY13 | $9.4B | $2B |
| FY12 | $13.9B | $2.3B |
| FY11 | $13.9B | $2.2B |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 30.1% | −2.7% | −8.5% |
| FY24 | 37.5% | 0.1% | −6.1% |
| FY23 | 40.1% | 6.8% | 25.6% |
| FY22 | 35.3% | −28.3% | −24.2% |
| FY21 | 38.9% | 11.1% | 10.6% |
| FY20 | 39.3% | 13.8% | 9.4% |
| FY19 | 41.9% | 15.6% | 8.8% |
| FY18 | 42.9% | 14.3% | 13.9% |
| FY17 | 42.3% | 12.2% | 5.7% |
| FY16 | 40.5% | 7.3% | 48.9% |
| FY15 | 42% | 5.7% | 9.7% |
| FY14 | 42.7% | 6.1% | 23.3% |
| FY13 | 44.2% | 5.3% | 21.4% |
| FY12 | 51.2% | - | 16.7% |
| FY11 | 50.7% | - | 16% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $332M |
| FY24 | $573M |
| FY23 | $1.3B |
| FY22 | $834M |
| FY21 | $1.5B |
| FY20 | $1.2B |
| FY19 | $1.4B |
| FY18 | $1.4B |
| FY17 | $1.1B |
| FY16 | $935M |
| FY15 | $860M |
| FY14 | $2.3B |
| FY13 | $2.5B |
| FY12 | $1.9B |
| FY11 | $1.9B |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $348M | - |
| FY24 | $590M | $0 |
| FY23 | $586M | $0 |
| FY22 | $573M | $32M |
| FY21 | $530M | $600M |
| FY20 | $473M | $500M |
| FY19 | $423M | $1.3B |
| FY18 | $376M | $2.5B |
| FY17 | $315M | $564M |
| FY16 | $268M | $292M |
| FY15 | $910M | - |
| FY14 | $1.1B | $550M |
| FY13 | $1B | $913M |
| FY12 | $804M | $1.5B |
| FY11 | $709M | $1.6B |
- Baxter International
- Healthcare median
Show the numbers
| Year | Baxter International | Healthcare median |
|---|---|---|
| FY25 | −8.5% | −30.6% |
| FY24 | −6.1% | −47% |
| FY23 | 25.6% | −58% |
| FY22 | −24.2% | −80.4% |
| FY21 | 10.6% | −71.9% |
| FY20 | 9.4% | −62.2% |
| FY19 | 8.8% | −46.3% |
| FY18 | 13.9% | −49.6% |
| FY17 | 5.7% | −45.9% |
| FY16 | 48.9% | −36% |
| FY15 | 9.7% | −38.4% |
| FY14 | 23.3% | −35.5% |
| FY13 | 21.4% | −37.1% |
| FY12 | 16.7% | −29.1% |
| FY11 | 16% | −27.9% |